Herbas VPB

Print
EN | LT
LT - GLYCAN-MODIFIED ANTI-CD4 ANTIBODIES FOR HIV PREVENTION AND THERAPY
EN - GLYCAN-MODIFIED ANTI-CD4 ANTIBODIES FOR HIV PREVENTION AND THERAPY

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07K 16/28
A61K 39/395
A61P 31/18
European patent
(11) Number of the document 2934589
(13) Kind of document T
(96) European patent application number 13866337.2
Date of filing the European patent application 2013-12-18
(97) Date of publication of the European application 2015-10-28
(45) Date of publication and mention of the grant of the patent 2021-01-13
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2013/076051
Date 2013-12-18
PCT application publication
(87) Number WO 2014/100139
Date 2014-06-26
Priority applications
(30) Number Date Country code
201261738777 P 2012-12-18 US
201361864942 P 2013-08-12 US
Inventors
(72)
SONG, Ruijiang, US
HO, David, D., US
Grantee
(73) The Rockefeller University, 1230 York Avenue, New York, NY 10065, US
Title
(54) GLYCAN-MODIFIED ANTI-CD4 ANTIBODIES FOR HIV PREVENTION AND THERAPY
  GLYCAN-MODIFIED ANTI-CD4 ANTIBODIES FOR HIV PREVENTION AND THERAPY
Last update date 2021-06-30